Neurocrine Biosciences (NBIX) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $157.79 +0.66%
EPS Growth %: -12.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -12.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.64, $0.05 better than the analyst estimate of $0.59. Revenue for the quarter came in at $296 million versus the consensus estimate of $296.65 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
- Snowflake soars 20% on earnings beat and raised guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
